Frank M Svoboda

Co-Chairman & CEO Frank M Svoboda sells 20,000 shares (27.0% of non-derivative holding) for $3.3M across 4 transactions at $164.20–$166.93

Frank M Svoboda, who was Co-Chairman & CEO at the time of filing, executed 4 separate sales totaling 20,000 shares (20.0K shares) for $3,315,645.76 ($3.3M) at prices ranging from $164.20 to $166.93, reducing his non-derivative holdings from 74,020 shares to 54,020 shares (-27.0% vs pre-transaction holdings). The transactions occurred on 2026-06-11 and 2026-06-12, with a blended average price of $165.78, near the current price of $169.06 and within 0.3% of the 52-week high of $169.50. Svoboda retains 10,000 shares through employee stock options (Table II derivative holdings), so his overall position remains substantial. His cross-ticker track record shows 20 prior sells with an average 90-day return of +3.1% and a 53.85% well-timed rate; however, his same-ticker history at GL shows 5 prior sales with only 2 measurable 30-day outcomes (both marginally positive), and no completed 90-day windows yet, making predictive assessment of this sale's timing impossible. The stock has risen 9.0% in 30 days and 21.0% in 90 days; whether this sale represents a tactical reduction or scheduled vest-and-sell activity cannot be determined from the filing alone.

Frank M Svoboda sold 20,000 shares at blended avg $156.68 for $3.1M; post-sale holdings 54,020 shares (-27.0% reduction).

Frank M Svoboda, who was Co-Chairman & CEO of Globe Life Inc., executed 2 separate sales totaling 20,000 shares for $3,133,587.54 at prices ranging from $156.65 to $157.05 on 2026-05-22, reducing his stake from 74,020 to 54,020 shares. The sales occurred at prices very close to the 52-week high of $157.92 (current price $156.70 is -0.8% from that peak), and the stock has risen +2.7% in the prior 30 days and +8.7% in the prior 90 days. His prior 5 trades at this ticker all resulted in subsequent positive returns at the 90-day mark (ranging from +1.3% to +1.8%), with 0 of 5 classified as well-timed on that metric, suggesting his recent sell pattern at this ticker has not preceded material declines. The company trades at a P/E of 10.34 with stable fundamentals (revenue $1,559,619,000.00, net income $270,526,000.00, annual revenue growth +3.7%), indicating no obvious fundamental distress signal.

CEO Frank Svoboda executes large sale near 52-week highs while maintaining buy activity, signaling selective profit-taking.

Frank Svoboda, Globe Life's Co-Chairman and CEO, executed a complex transaction pattern on consecutive days that reveals selective profit-taking rather than wholesale portfolio reduction. Despite a net outflow of over $2.3 million in sales, Svoboda simultaneously made material purchases, suggesting he is pruning positions that have appreciated while maintaining conviction in the company. The stock is currently trading near its 52-week high and has appreciated meaningfully over the past quarter — a classic setup for insider profit-taking without abandonment. Historically, Svoboda's prior sales in this stock preceded periods where the stock either fell or remained flat, making his timing track record reasonably reliable. The underlying company remains fundamentally sound and profitable, indicating Svoboda is not panicking but rather making deliberate rebalancing decisions at an attractive price level.

Co-Chairman and CEO Frank Svoboda exercises and immediately sells equal-sized blocks, netting $530k gain while stock trades near 52-week highs.

Frank Svoboda, Globe Life's Co-Chairman and CEO, exercised 10,000 shares and sold 10,000 shares in the same transaction date, creating a net-zero change in his position. This is a classic equity exercise-and-sell pattern — compensation vesting followed by immediate liquidation — rather than a reflection of insider conviction about the stock's direction. The sales occurred as the stock trades near its 52-week highs, a common window for executives to realize value from vested equity without signaling concerns about future performance. Svoboda's prior Form 4 activity over the past three years shows 23 prior open-market sales against only 2 purchases, establishing a strong seller-oriented pattern. At the ticker level, his five prior sells at Globe Life show mixed timing results — three were well-timed exits (the stock fell after those sales) while two were poorly timed (the stock rose afterward) — indicating inconsistent success reading this specific company's near-term direction. Against a backdrop of solid company fundamentals—profitable operations with modest revenue growth and reasonable valuation—this transaction reads as routine equity management rather than a directional bet.

CEO Frank Svoboda sold 12,500 shares at blended average $144.78 for $1.8M, reducing GL holdings by 25.8%.

Frank Svoboda, Co-Chairman & CEO of Globe Life Inc., executed 3 separate sales totaling 12,500 shares on 2026-02-17 for $1,809,702.37, with transaction prices ranging from $143.95 to $145.52. The sale represents a material reduction: his post-transaction holdings of 35,868 shares are 25.8% lower than the 48,368 shares held before the transaction. At the same-ticker level, his prior 5 GL trades show a consistent pattern of well-timed sells at the 90-day mark, with 3 of 3 prior sells showing negative 90-day returns (-1.5%, -1.0%, -1.2% at 30 days; -7.2%, -6.8%, -5.1% at 90 days). The current stock price of $143.60 is 2.3% below the 52-week high of $146.95, and the blended transaction average of $144.78 sits near the high end of the current range, consistent with his historical execution pattern at this ticker. The company's fundamentals remain solid—P/E of 9.94, annual revenue growth of 6.1%, and $387.8M net income on $1.5B quarterly revenue—suggesting this transaction reflects positioning rather than fundamental distress.

CEO Frank M Svoboda sold 9,379 shares at $140.27–$140.79 for $1.3M, reducing stake 20.7%

Frank M Svoboda, Co-Chairman & CEO of Globe Life Inc., executed 2 separate sales totaling 9,379 shares for $1,317,072.32 at a blended average price of $140.43 on 2025-12-16, reducing his holdings from 45,247 to 35,868 shares (a 20.7% reduction). At the same-ticker level, his prior 5 trades at GL show a strong 80% well-timed rate at the 90-day mark, with 4 of the last 5 sales preceding subsequent stock declines. The stock currently trades at $138.73, down 5.3% from its 52-week high of $146.55, having appreciated 5.6% over the past 30 days. The company's fundamentals remain solid: $1.5B in latest-quarter revenue, net income of $387.8M, and a low P/E of 9.60 on an $11.0B market cap. The timing pattern at this ticker—with prior sales generally preceding weakness rather than strength—warrants attention, though the current price action shows mixed momentum (recent monthly strength offset by longer-term range constraint).

CEO Svoboda sells 25,000 GL shares (43.3% of holdings) in 4 transactions for $3.5M at $141.58 blended avg on Jul 30-31

Frank M. Svoboda, Co-Chairman & CEO, executed 4 separate sales totaling 25,000 shares for $3,539,582.71 over two consecutive trading days (July 30-31), reducing his holdings from 57,747 to 32,747 shares (-43.3%). The transactions occurred at prices ranging from $141.30 to $142.02, near the stock's current price of $140.47 and approximately 2.0% below the 52-week high of $143.27. The stock has gained 12.5% in the prior 30 days and 15.3% over 90 days, suggesting the sales follow a period of strength. Svoboda's prior trades at Globe Life show a 100% well-timed rate at the 90-day mark on two measurable sales (Feb 2025), though more recent GL sales from June and May lack completed 90-day outcome data. The substantial reduction in his ownership stake warrants investor attention given the CEO's direct influence on company strategy and operational performance.

Co-Chairman & CEO Svoboda sells 6,051 GL shares for $733,616.95; reduces stake 15.6%; stock +0.6% (30d), -3.0% (90d).

Frank M. Svoboda, Co-Chairman & CEO of Globe Life Inc., sold 6,051 shares (5,551 at $121.19 and 500 at $121.75 on 2025-06-04) for a combined $733,616.95, reducing his holdings from 38,798 to 32,747 shares, a -15.6% decline. At his same ticker, his prior 4 measurable sales all showed negative 90-day returns (-2.5%, -2.1%, -1.5%, -0.4%), meaning all 4 prior sells were well-timed relative to subsequent stock performance. However, this sale cannot yet be evaluated on timing grounds since 90-day outcome is not yet measurable. The company trades at a P/E of 9.38 with $1.5B quarterly revenue and $254.6M net income, reflecting modest fundamentals relative to its $10.0B market cap. The stock is currently -8.6% from its 52-week high, and the blended sale price of $121.24 sits between the current price of $121.70 and the historical range, offering no obvious sign of distress pricing or euphoric valuations.

Co-Chairman & CEO Frank M Svoboda sold 6,019 shares of GL at $122.51, reducing stake 16.1%; prior 5 trades at GL all well-timed at 90-day mark

Svoboda sold 6,019 shares (31.3K shares remaining) at $122.51 on 2025-05-20, capturing a price 1.9% above the current $120.20 level. His same-ticker trade history at GL is notable: all 5 prior sales showed negative 90-day returns (ranging from -2.5% to -0.4%), indicating consistent well-timed exits before declines. This current transaction occurs with GL trading -9.7% from its 52-week high, suggesting the stock has already retreated from recent peaks. Cross-ticker, his 11 prior open-market sales showed a 45.45% well-timed rate with +3.0% average 90-day return—a mixed record—but his GL-specific pattern of 100% well-timed sells (5 of 5) at this ticker stands out as materially stronger. The stock's fundamentals remain solid: P/E of 9.26, +6.1% annual revenue growth, and $1.5B quarterly revenue, which do not suggest fundamental distress, but the timing pattern and the sale price relative to current levels warrant attention.

CEO Svoboda sells 21,750 GL shares across 3 transactions (Feb 13–14) for $2.7M at avg $122.42; holds 18,948 shares post-sale

Frank M. Svoboda, Co-Chairman & CEO of Globe Life Inc., executed 3 separate sales totaling 21,750 shares for $2,662,709.25 at a blended average price of $122.42 over two trading days (February 13–14, 2025). This sale reduced his holdings by 53.4% versus pre-transaction levels. At the current price of $121.84, the stock is -5.1% from its 52-week high of $128.40 and has gained +4.9% over the trailing 30 days. Svoboda's prior trading history at GL shows 5 recent sales, with measurable near-term outcomes on three of them showing positive 30-day returns (+9.6%, +8.8%, +3.2%), though 90-day outcomes remain incomplete; his cross-ticker sell track record shows a 0.00% well-timed rate at the 90-day horizon, meaning prior sells did not precede declines. The company's fundamentals show a P/E of 9.38 and annual revenue growth of +4.5%, with a market cap of $10.2B.